Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate versus gabapentin for post-dural puncture headache after cesarean spinal anesthesia
IRCT20261007071343N1Phase 3Not yet recruiting
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of gabapentin and magnesium sulfate in post-dural puncture headache (PDPH) (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Reduction in Visual Analogue Scale for pain. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
gabapentinmagnesium sulfate
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20261007071343N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20261007071343N1.